查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1790357

美國乳房保留手術市場規模、佔有率及趨勢分析報告：按手術類型、產品、最終用途和細分市場進行預測（2025-2033 年）

U.S. Breast Conserving Surgery Market Size, Share & Trends Analysis Report By Procedure (Lumpectomy, Quadrantectomy, Segmental Mastectomy), By Product, By End Use (Hospitals, Ambulatory Surgery Centers), And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10個工作天內

價格

市場規模和趨勢

預計 2024 年美國乳房保留手術市場價值將達到 7.4432 億美元，預計 2025 年至 2033 年的複合年成長率為 7.18%。

市場成長的動力源自於早期乳癌盛行率的不斷上升，這得益於乳房X光攝影檢查篩檢計畫和病患意識提升宣傳活動的廣泛發展。這些措施提高了早期發現率，使更多患者有資格接受乳房腫瘤切除術和切除術等乳房保留手術。此外，尤其是年輕患者，強烈渴望接受能夠保留乳房外觀和功能的手術，這符合乳房保留手術 (BCS) 的原則。

門診手術設施的成長是美國市場的主要驅動力，它們為住院手術提供了經濟高效且對患者友好的替代方案。這些設施擴大配備了先進的手術技術、經驗豐富的醫護人員和精簡的流程，通常非常適合像BCS這樣創傷性較小、恢復時間較短的手術。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章美國乳房保留手術市場變數、趨勢與範圍

  • 市場體系展望
    • 相關/輔助市場展望
  • 使用者觀點分析
    • 消費行為分析
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
    • 市場問題分析
  • 美國乳房保留手術市場分析工具
    • 產業分析—波特五力分析
    • PESTEL分析

第4章美國保乳手術市場：依手術類型、估價及趨勢分析

  • 細分儀表板
  • 美國乳房保留手術市場：2024 年及 2033 年手術變異分析及市場佔有率
  • 切除術
  • 切除術
  • 部分乳房切除術

第5章：美國保乳手術市場：產品、估值與趨勢分析

  • 細分儀表板
  • 美國乳房保留手術市場：2024 年和 2033 年產品變化分析和市場佔有率
  • 腫瘤定位裝置
    • 有線引導定位
    • 磁性種子定位
    • 基於雷達的定位
    • 其他
  • 手術切除裝置
    • 電外科手術單元/設備
    • 手術刀/鑷子/牽開器/夾子
    • 真空切片檢查系統
    • 其他
  • 裕度評估裝置
  • 術中成像和導航設備

第6章美國保乳手術市場：以最終用途的估計和趨勢分析

  • 細分儀表板
  • 美國乳房保留手術市場：2024 年和 2033 年最終用途變化分析和市場佔有率
  • 醫院
  • 門診手術中心
  • 腫瘤科/專科診所
  • 其他

第7章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司/競爭對手分類
    • 創新者
  • 供應商格局
    • 主要經銷商和通路合作夥伴名單
    • 2024年主要企業市場佔有率分析
    • Hologic, Inc
    • Argon Medical Devices
    • Merit Medical Systems
    • KUBTEC
    • Stryker
    • Mammotome（Danaher）
    • CairnSurgical Inc.
    • Lumicell Inc
    • Innoblative Designs
    • Perimeter Medical Imaging AI
Product Code: GVR-4-68040-660-3

Market Size & Trends:

The U.S. breast conserving surgery market size was estimated at USD 744.32 million in 2024 and is projected to grow at a CAGR of 7.18% from 2025 to 2033. The market growth is attributed to the rising prevalence of early-stage breast cancer, supported by widespread mammography screening programs and patient awareness campaigns. These initiatives have led to an increase in early detection rates, making more patients eligible for breast-conserving procedures like lumpectomy and quadrantectomy. In addition, there is a strong preference for procedures that preserve breast appearance and function, especially among younger patients, which aligns with the principles of breast conserving surgery (BCS).

The growth of ambulatory surgical settings is a key driver of the U.S. market, offering a cost-effective, patient-friendly alternative to inpatient hospital procedures. These settings are increasingly equipped with advanced surgical technologies, experienced staff, and streamlined processes that make them well suited for procedures like BCS, which are typically less invasive and have shorter recovery times.

U.S. Breast Conserving Surgery Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. breast conserving surgery market report based on procedure, product, and end use:

  • Procedure Outlook (Revenue, USD Million, 2021 - 2033)
  • Lumpectomy
  • Quadrantectomy
  • Segmental Mastectomy
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Tumor Localization Devices
    • Wire-guided localization
    • Magnetic seed localization
    • Radar-based localization
    • Others
  • Surgical Excision Devices
    • Electrosurgical units/devices
    • Scalpels/forceps/retractors/clamps
    • Vacuum-assisted biopsy systems
    • Others
  • Margin Assessment Devices
  • Intraoperative Imaging & Navigation Devices
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Ambulatory Surgery Centers
  • Oncology/Specialty Clinics
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Third Party Perspective
    • 1.3.5. Primary research
    • 1.3.6. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights Outlook

Chapter 3. U.S. Breast Conserving Surgery Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Related/ancillary market outlook.
  • 3.2. User Perspective Analysis
    • 3.2.1. Consumer behavior analysis
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
      • 3.3.1.1. Increasing breast cancer incidence and focus on early detection
      • 3.3.1.2. Rising preference for cosmetic and functional preservation
      • 3.3.1.3. Technological advancement in wireless localization and AI-based margin assessment
      • 3.3.1.4. Growth of ambulatory surgical settings
      • 3.3.1.5. Favorable government and reimbursement support in developed nations
    • 3.3.2. Market restraint analysis
      • 3.3.2.1. High cost of advanced technologies
      • 3.3.2.2. Limited access to early diagnosis
    • 3.3.3. Market opportunity analysis
      • 3.3.3.1. Shift toward outpatient & minimally invasive procedures
    • 3.3.4. Market challenge analysis
      • 3.3.4.1. Reoperation risk due to positive margins
  • 3.4. U.S. Breast Conserving Surgery Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. U.S. Breast Conserving Surgery Market: Procedure Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Breast Conserving Surgery Market: Procedure Movement Analysis & Market Share, 2024 & 2033
  • 4.3. Lumpectomy
    • 4.3.1. Lumpectomy Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Quadrantectomy
    • 4.4.1. Quadrantectomy Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Segmental Mastectomy
    • 4.5.1. Segmental Mastectomy Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Breast Conserving Surgery Market: Product Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Breast Conserving Surgery Market: Product Movement Analysis & Market Share, 2024 & 2033
  • 5.3. Tumor Localization Devices
    • 5.3.1. Tumor Localization Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.2. Wire-Guided Localization
      • 5.3.2.1. Wire-guided localization market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.3.3. Magnetic Seed Localization
      • 5.3.3.1. Magnetic seed localization market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.3.4. Radar-Based Localization
      • 5.3.4.1. Radar-based localization market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.3.5. Others
      • 5.3.5.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.4. Surgical Excision Devices
    • 5.4.1. Surgical Excision Devices Market Estimates And Forecasts 2021 to 2033 (USD Million)
    • 5.4.2. Electrosurgical Units/Devices
      • 5.4.2.1. Electrosurgical units/devices market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.3. Scalpels/Forceps/Retractors/Clamps
      • 5.4.3.1. Scalpels/forceps/retractors/clamps market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.4. Vacuum-Assisted Biopsy Systems
      • 5.4.4.1. Vacuum-assisted biopsy systems market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.5. Other
      • 5.4.5.1. Other market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5. Margin Assessment Devices
    • 5.5.1. Margin Assessment Devices Market Estimates And Forecasts 2021 to 2033 (USD Million)
  • 5.6. Intraoperative Imaging & Navigation Devices
    • 5.6.1. Intraoperative Imaging & Navigation Devices Market Estimates And Forecasts 2021 to 2033 (USD Million)

Chapter 6. U.S. Breast Conserving Surgery Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Breast Conserving Surgery Market: End Use Movement Analysis & Market Share, 2024 & 2033
  • 6.3. Hospitals
    • 6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Ambulatory Surgery Centers
    • 6.4.1. Ambulatory Surgery Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Oncology/Specialty Clinics
    • 6.5.1. Oncology/Specialty Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
    • 7.2.1. Innovators
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2024
    • 7.3.4. Hologic, Inc
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Argon Medical Devices
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Merit Medical Systems
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. KUBTEC
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Stryker
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Mammotome (Danaher)
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. CairnSurgical Inc.
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Lumicell Inc
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Innoblative Designs
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives
    • 7.3.13. Perimeter Medical Imaging AI
      • 7.3.13.1. Company overview
      • 7.3.13.2. Financial performance
      • 7.3.13.3. Product benchmarking
      • 7.3.13.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 U.S. breast conserving surgery market, by procedure, 2021 - 2033 (USD Million)
  • Table 4 U.S. breast conserving surgery market, by product, 2021 - 2033 (USD Million)
  • Table 5 U.S. breast conserving surgery market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Breast conserving surgery market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2024)
  • Fig. 10 Segment outlook
  • Fig. 11 Strategy framework
  • Fig. 12 Penetration & growth prospect mapping
  • Fig. 13 Consumer behavior analysis
  • Fig. 14 Market driver relevance analysis (Current & future impact)
  • Fig. 15 Market restraint relevance analysis (Current & future impact)
  • Fig. 16 Porter's Five Forces analysis
  • Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 18 Lumpectomy market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Quadrantectomy market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Segmental mastectomy market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Tumor localization devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Wire-guided localization market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Magnetic seed localization market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Radar-based localization market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Surgical excision devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Electrosurgical units/devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Scalpels/forceps/retractors/clamps market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Vacuum-assisted biopsy systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Margin assessment devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Intraoperative imaging & navigation devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Ambulatory surgery centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Oncology/specialty clinics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Company market share analysis, 2024
  • Fig. 38 Market differentiators